Study of XL114 in Subjects With Non-Hodgkin's Lymphoma

NCT05144347 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Due to Sponsor reasons.

Conditions

Non-Hodgkin's Lymphoma (NHL)
Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)
Mantle Cell Lymphoma (MCL)
Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)

Interventions

DRUG: XL114

Sponsor

Exelixis